Yan Gong

Yan Gong Ph.D.

Associate Professor

Department: Pharmacotherapy & Translational Research
Business Phone: (352) 273-6297
Business Email: gong@cop.ufl.edu

About Yan Gong

Yan Gong, Ph.D., is an Associate Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida (UF) College of Pharmacy and the UF Center for Pharmacogenomics. Dr. Gong received a Ph.D. in Pharmaceutics in 2004 from Department of Pharmaceutics, College of Pharmacy at UF. She also obtained a Master’s Degree in Statistics in 2003 from UF Department of Statistics. Before joining the UF faculty in 2005, she completed one year of post-doctoral fellowship in Cardiovascular Pharmacogenomics at the UF Center for Pharmacogenomics.

Dr. Gong’s research focuses on pharmacogenomics and disease-gene association that may be relevant to pharmacogenomics. The majority of her research so far has centered on Pharmacogenomics of hypertension and cardiovascular adverse outcomes. Dr. Gong has been an investigator on multiple randomized controlled hypertension clinical trials such as International VErapamil Trandolapril Study (INVEST), Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) and Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR2). Over the years, Dr. Gong has also developed interest in pharmacogenomics of serious adverse drug events. She is currently collaborating with local and international investigators on the pharmacogenomics of medication-related osteonecrosis of the jaw (ONJ) and most recently pharmacogenomics of cardiomyopathy associated with targeted cancer therapies.

In addition to research, Dr. Gong has been involved in teaching multiple graduate level and professional level courses at the University of Florida, College of Pharmacy and College of Medicine. She is currently the course coordinator for Pharmacogenomics (PHA6449), a required graduate level course at the College of Pharmacy.

Publications

2015 Cancer Treatment Reviews
2014 Journal of the American Society of Hypertension

Grants

September 2018ACTIVE
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
NATL INST OF HLTH NICHD · Project Manager
August 2018ACTIVE
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
NATL INST OF HLTH NICHD ·
April 2017ACTIVE
OoR CTSI Institutional Matching Support
UF DIV OF SPONSORED RES MATCHING FUNDS · Project Manager
April 2017ACTIVE
HSC COM Matching Commitment
UNIV OF FLORIDA · Project Manager
July 2016 – June 2019
A stem cell tactic to promote personalized medicine
NATL INST OF HLTH NIGMS · Project Manager
June 2016 – August 2018
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
NATL INST OF HLTH NICHD · Project Manager
October 2015 – March 2019
OneFlorida Clinical Research Consortium Phase II
PATIENT-CENTERED OUTCOMES RES INST ·
April 2015ACTIVE
Clinical and Translational Science Institute (CTSI)
UF DIV OF SPONSORED RES MATCHING FUNDS · Project Manager
June 2014ACTIVE
Mechanisms and Treatment Response of Aggressive Periodontitis in Children
NATL INST OF HLTH NIDCR · Project Manager

Education

2004
Ph.D.
University of Florida
2003
M.S.
University of Florida
1999
M.S.
West China University of Medical Sciences